Evidence map›Paper›PMID 39926117›Full record

ArticleNeuropsychiatric disease and treatment2025

The Prevalence of Depression Among Parkinson's Disease Patients in Saudi Arabia: A Cross-Sectional Study.

Zainah Al-Qahtani, Abdulrahman Saad M Alqahtani, Abdulmohsin Mohammed S Alzuhairi, Mohammed Qarah, Albara A Alqarni, Abdulaziz Othman M Alqahtani, Fahad Abdullah A AlShehri, Muath Abdullah A Alqathanin, Omair Mohammed O Alshahrani, Mohammed Ali F Alqahtani and 1 more

Abstract read
In one paragraph

Article in Neuropsychiatric disease and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zainah Al-QahtaniNeurology Section, Internal Medicine Department, College of Medicine, King Khalid University, Abha, 61421, Saudi Arabia.
Abdulrahman Saad M AlqahtaniAseer Cluster Health, Abha, Saudi Arabia.
Abdulmohsin Mohammed S AlzuhairiKing Khalid University, Abha, Saudi Arabia.
Mohammed QarahPublic Health Department, Saudi Board of Preventive Medicine, Madinah, Saudi Arabia.
Albara A AlqarniKing Khalid University, Abha, Saudi Arabia.
Abdulaziz Othman M AlqahtaniCollege of Medicine King Khalid University, Abha, Saudi Arabia.
Fahad Abdullah A AlShehriKing Khalid University, Abha, Saudi Arabia.
Muath Abdullah A AlqathaninInternal Medicine Department, Saudi Board of Internal Medicine, Abha, Saudi Arabia.
Omair Mohammed O AlshahraniKing Khalid University, Abha, Saudi Arabia.
Mohammed Ali F AlqahtaniCollege of Medicine King Khalid University, Abha, Saudi Arabia.
Syed Esam MahmoodDepartment of Family and Community Medicine, College of Medicine, King Khalid University, Abha, 61421, Saudi Arabia.ORCID 0000-0001-5264-5677

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: Depression is thought to affect up to half of Parkinson's patients at some point during their illness, while anxiety is reported by about 40% of PD patients. The study aimed to assess the prevalence of depression and anxiety among patients with Parkinson's disease (PD) in Saudi Arabia. Methods: The study involved Saudi Arabian citizens and residents aged 40 or older with PD, who completed internet-survey (including online and email-based data collection) or telephone-survey by trained interviewers. We used the Parkinson's Disease Questionnaire for quality-of-Life assessment questionnaire (PDQ-39), Patient Health Questionnaire-9 for depression (PHQ-9), and General Anxiety Disorder-7 anxiety questionnaire (GAD-7). Results: The study included 46 participants, of whom 37% were aged 60-69 years, 67% were male, 46% had completed a university education, and 87% were married. Depression symptoms were present in 84.8% of participants, while 73.9% experienced anxiety. PD patients lacking social support were 8 times more likely to develop major depression [OR = 8.27, 95% CI (1.47-46.31), p = 0.016] and 5 times more likely to experience anxiety symptoms [OR = 5.36, 95% CI (1.14-25.26), p = 0.034]. Those unable to perform daily living activities or who faced stigma had a 16.5 times higher likelihood of anxiety symptoms [OR = 16.5, 95% CI (1.62-168.48), p = 0.018]. Furthermore, cognitive impairment increased the likelihood of anxiety by 11 times [OR = 11.43, 95% CI (1.83-71.42), p = 0.009]. Conclusion: The study reveals a high prevalence of depression and anxiety among Parkinson's disease patients, linked to physical impairments and social isolation. Many patients report no mental health improvement despite treatment, highlighting the need for routine mental health assessments, social support, and tailored interventions to enhance their quality of life. The small sample size may limit the statistical power, precision, and generalizability of the study's findings.

Indexed as

anxietydepressionParkinson diseaseSaudi Arabia

Identifiers

PMID39926117
PMCPMC11806747

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.